INTERVIEW: Tackling Asia’s Oncology Access Hurdles
This article was originally published in PharmAsia News
Executive Summary
Industry may be doing its part to develop novel and effective cancer therapies, but one major multinational sees room for further regulatory improvements and partnerships to help ensure earlier and broader access to new drugs.